Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia

Abstract

Purpose: The aim of this study was to compare the evolution of systemic cytokine levels over time in patients with pneumococcal pneumonia treated either with ß-lactam monotherapy or with combination therapy (ß-lactam plus fluoroquinolone). Methods: Prospective observational study of hospitalized non-immunocompromised adults with PP. Concentrations of IL-6, IL-8, IL-10 and TNF-α were determined on days 0, 1, 2, 3, 5, and 7. Patients on ß-lactam monotherapy were compared with those receiving combination therapy. Results: Fifty-two patients were enrolled in the study. Concentrations of IL-6, IL-8, and IL-10 decreased rapidly in the first days after admission, in accordance with the mean time to defervescence. High levels of IL-6 were found in patients with the worst outcomes, measured by the need for intensive care unit admission and mortality. No major differences in demographic or clinical characteristics or severity of disease were found between patients treated with ß-lactam monotherapy or combination therapy. IL-6 levels fell more rapidly in patients with combination therapy in the first 48 hours (p=0.016). Conclusions: Our data suggest that systemic expression of IL-6 production in patients with PP is correlated with prognosis. Initial combination antibiotic therapy produces a faster decrease in this cytokine in the first 48 hours. We submitted you the revised manuscript entitled "Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia". We have taken into consideration all the reviewer's suggestions. Please find below a list of responses point by point to the reviewers' comments. Sincerely, Carolina Garcia-Vidal Infectious Diseases Service. Hospital Universitari de Bellvitge Feixa llarga s/n. 08907 L'Hospitalet, Barcelona, Spain E-mail: caroglv75@hotmail.com Fax: 34 93 2607637Comments to the Author:Reviewer #1: Prospective, non randomized study on the evolution and the impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia. A total of 52 patients enrolled. Data on the evolution of the systemic cytokine levels obtained every 24 hours during the first 5 days and on day 7. In 39 selected patients, the impact of B-lactam alone vs. Blactam plus fluoroquinolone on the systemic cytokine levels was assessed. Results showed that high levels of IL-6 at inclusion predicted the worst outcomes, including admission to ICU and mortality. In the group of patients treated with the combination, IL-6 levels fell more rapidly in the first 48 hours. COMMENTSThe study confirms previous reports that have shown a correlation of IL-6 levels at entry and prognosis. The results of the comparative study on the impact of antibiotic therapy showed that combination therapy was associated with a faster decrease in IL-6 in the first 24 and 48 hours of treatment. The Introduction, Methods and Results are appropriate and pertinent information is provided. In the Discussion, the authors elaborate considerably on the potential advantages of combination vs. monotherapy in C...

Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia

“…25 mg/dL) may be useful in diagnosing L pneumophila with high Prior use of antibiotics reduced the levels of PCT and cytokines, mainly IL-6 and IL-10, suggesting that the infl ammatory phase was beginning to be downregulated. 11,17 We consider that PCT-guided antibiotic prescription in CAP requires extreme caution in patients with prior antibiotic treatment because it could underestimate bacterial cause, 9,10 and even in those without prior antibiotics it would appear that a low PCT has insuffi cient NPV to exclude pathogens. NPV (94%).…”

Increased production of interleukin-10 in children with Down syndrome upon ex vivo stimulation with Streptococcus pneumoniae

“…Hence, IL-6 downregulates the activation of the cytokine network in the lung, by controlling the activation of both agonist and antagonist mediators during pneumococcal pneumonia, and thus contributes to host defense (36). However, in humans with pneumococcal pneumonia, high levels of IL-6 in serum were associated with a more frequent admission to the intensive care unit and also a higher mortality (37,38). In complicated pneumococcal pneumonia with pleural effusion in children, increased release of proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 in pleural fluid resulted in increased complications with the formation of fibrin deposition requiring surgical intervention (35,39).…”

The influence of etiological factors on immunoreactivity in patients with community-acquired pneumonia

“…Известно также, что концентрация IL6, IL8 и IL10 снижается в первые несколько дней от начала лечения. Сохранение высокого уровня цитокинов, особенно IL6, является неблагоприятным признаком [20]. В нашей работе наиболее высокий уровень IL6 (100 пг/мл) был выявлен у пациентов с атипичными возбудителями, в то время как IL8 у данной категории больных был ниже предела чувствительности метода в 100% случаев.…”